Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 10 Days Versus Clarithromycin in the Treatment of Community-Acquired Pneumonia.
Phase of Trial: Phase III
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Clarithromycin; Faropenem medoxomil
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Adverse reactions; Therapeutic Use
- 25 Jul 2011 New trial record